01 1APICHEM Laboratories Private Limited
02 1Ash Stevens LLC
03 1Catalent Micron Technologies, Inc.
04 1Maithri Drugs Private Limited
05 1SK biotek Ireland Limited
01 5Mavacamten
01 1China
02 1India
03 3U.S.A
NDC Package Code : 48957-0091
Start Marketing Date : 2022-04-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69988-0060
Start Marketing Date : 2022-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 81666-008
Start Marketing Date : 2025-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-050
Start Marketing Date : 2024-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50193-4423
Start Marketing Date : 2024-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
61
PharmaCompass offers a list of Mavacamten API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mavacamten manufacturer or Mavacamten supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mavacamten manufacturer or Mavacamten supplier.
PharmaCompass also assists you with knowing the Mavacamten API Price utilized in the formulation of products. Mavacamten API Price is not always fixed or binding as the Mavacamten Price is obtained through a variety of data sources. The Mavacamten Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A QX45B99R3J manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of QX45B99R3J, including repackagers and relabelers. The FDA regulates QX45B99R3J manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. QX45B99R3J API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of QX45B99R3J manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A QX45B99R3J supplier is an individual or a company that provides QX45B99R3J active pharmaceutical ingredient (API) or QX45B99R3J finished formulations upon request. The QX45B99R3J suppliers may include QX45B99R3J API manufacturers, exporters, distributors and traders.
click here to find a list of QX45B99R3J suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing QX45B99R3J as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for QX45B99R3J API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture QX45B99R3J as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain QX45B99R3J and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a QX45B99R3J NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of QX45B99R3J suppliers with NDC on PharmaCompass.
We have 5 companies offering QX45B99R3J
Get in contact with the supplier of your choice:
